German Biotech Firm Wins Award for Technology Innovation

The German biotechnology company MWG Biotech AG (Ebersberg; www.mwg-biotech.com) has received the Technology Innovation Award of 2004 from Frost & Sullivan (London, UK; www.frost.com).

Frost & Sullivan, a global leader in growth consulting, presents the award for the achievements of a company whose research programs have resulted in innovations that have made, or are expected to make, significant contributions to the industry in terms of adoption, change, and competitive posture.

MWG Biotech was recognized for its proven synthesis technology, which is used to produce high quality (purified and salt-free) oligonucleotides much faster than HPLC (high-performance liquid chromatography) based approaches. In addition, the company has developed a new oligo process, which is based on a nontoxic hydrogel purification technique that removes n-1 products and depurinations from short and longer oligonucleotides, which is likely to outperform conventional polyacrylamide gel electrophoresis in terms of both quality and reproducibility.

"We are extremely proud of this award,” said Thomas Becker, CEO of MWG Biotech AG. "It clearly proves our innovative strength and the market leadership of our oligonucleotides as well as the valuable contribution they make to the production of our reliable, high quality MWG catalog and custom microarrays.”




Related Links:
MWG Biotech AG